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Abstract

DOES BISPHENOL-A, AN ESTROGEN-LIKE ENVIRONMENTAL TOXIN,
DISRUPT EXPRESSION OF THE NEURONAL CHLORIDE EXPORTER PROTEIN
DURING EARLY BRAIN DEVELOPMENT?

Mayra Selene Mendez

Bisphenol A (BPA), a manufactured compound found in consumer products, is known to
adversely affect early brain development by disrupting normal estrogen signaling.
Recently, BPA was reported to suppress expression of a gene encoding the neuronspecific chloride ion transporter, KCC2. Human and animal studies show suppressing
KCC2 can cause neuronal and behavioral hyperactivity. Therefore, some adverse effects
of BPA may be due to KCC2 suppression and consequent neuronal hyperactivity. This
study aimed to determine whether BPA exposure during brain development alters KCC2
expression. A secondary purpose was to evaluate whether a new transgenic zebrafish line,
KCC2:mCitrine, could be used to track changes in KCC2 expression in vivo by
fluorescence imaging. Zebrafish embryos treated with 2.5µM BPA during days 0-5 postfertilization were tested for (1) KCC2:mCitrine fluorescence brightness; (2) KCC2 gene
expression using RT qPCR as an external validation for fluorescence; (3) Behavioral
activity level, and; (4) estrogen signaling, as a BPA manipulation check. Results showed
that BPA produced expected estrogenic effects in the developing brain and decreased
KCC2 expression at specific developmental time points. However, BPA did not produce
ii

expected behavioral hyperactivity. Lastly, RT-qPCR data were uninterpretable so
fluorescence brightness could not be externally validated as a measure of gene
expression. This pattern of results supports the conclusion that estrogenic effects of BPA
can suppress KCC2 expression in developing zebrafish brain, consistent with previous
research implicating BPA as a teratogen, and KCC2 expression as a mechanism -- and
potential treatment target -- in human developmental disorders.
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Introduction

Each year, 1 in 54 people are diagnosed with autism spectrum disorder (Hyman et
al., 2020). Epilepsy is also a common brain disorder, affecting about 0.05% of the
population, or 1 in 200 people (Sander & Shorvon, 1996). Both of these neurological
disorders, and others, are characterized by increased brain electrical activity, and the
search for biological causes of neural hyperactivity has pointed toward dysfunctions in
the γ-aminobutyric acid (GABA) neurotransmitter system, which is the main inhibitory
neurotransmitter system in the brain. The following sections explain (a) how GABA’s
effect on neural activity depends on the regulation of chloride (Cl-) ions inside neurons;
(b) how disruption of one key protein that controls neuronal Cl- levels, called KCC2,
during early brain development, may lead to brain hyperactivity and neurological
disorders; and (c) how a widespread industrial chemical, bisphenol-A (BPA), may disrupt
KCC2 and increase the risk for disorders involving brain hyperactivity. Finally, I propose
an experiment in zebrafish to test the potential of BPA to disrupt KCC2 expression
during critical periods of brain development. The proposed experiment can be classified
as a developmental neurotoxicology study and as part of an effort being made by multiple
neuroscience researchers today to use animal models to assess the potential clinical
relevance of KCC2 expression levels.

GABA effects depend on intracellular chloride concentration
The neurotransmitter, GABA, is generally thought of as an inhibitory
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neurotransmitter because that is its function in most mature neurons. This fact about
GABA is known to most people who understand that the action of common depressant
drugs, such as alcohol and benzodiazepines, is to increase GABA effects. Such drugs
inhibit the brain. However, in immature neurons, such as neurons in a fetal brain, the
neurotransmitter, GABA, is excitatory. These varying effects of GABA signaling can be
explained by the concentration of chloride ions (Cl-) in the neuron. GABA, acting
through GABAA receptors (GABAAR), serves to open Cl- ion channels in neuron
membranes, but whether Cl- ions flow in or out of those channels depends on the baseline
concentration of Cl- in the neurons: if baseline concentration is low, diffusion forces Clto flow in when channels open, and this inhibits neurons because the membrane voltage
becomes more negative, but if baseline concentration starts high, Cl- ions will flow out,
increasing net positive charge and electrically exciting the neuron. The key to
understanding whether GABA is inhibitory or excitatory, therefore, is understanding the
regulation of Cl- concentration in neurons.

Control of intracellular Cl- by Cl- transporters during development
There are two ion transporters that are constantly regulating intracellular Cl- in
neurons, one that continuously pumps Cl- in and another that continuously pumps Clout. Both transporters are membrane-bound proteins comprised of twelve transmembrane
domains that use cellular energy to actively transport ions. The Cl- importer protein is
officially called the potassium-chloride cotransporter 1 (NKCC1). It is encoded by a gene
called SLC12a2 and is expressed in neurons and other tissues in the body (Ben-Ari,
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2002). The Cl- exporter protein, called the potassium–chloride cotransporter 2 (KCC2), is
encoded by the gene, SLC12a5, and is expressed only in neurons. These two proteins
have antagonistic effects on intracellular Cl- concentration, so their relative level of
activity determines net Cl- concentration in neurons. A major factor influencing the
activity of either transporter is the amount of gene transcription (gene activation), which
determines the number of copies of the protein that exist within the cell.
The major insight explaining why developing neurons switch from having
GABA-induced excitation to GABA inhibition is that expression of the Cl- exporter gene
is delayed relative to the Cl- importer (Barbato et al., 2010). Immature neurons
predominantly express Cl- importers, leading to high intracellular Cl- concentration.
When GABA signaling then occurs and opens Cl- diffusion channels, the diffusion force
pushes Cl- out of the cell down its concentration gradient (Ben-Ari, 2002). The rapid
outflow of negatively charged Cl- ions makes the neuron more electrically positive
relative to the extracellular fluid, which is the definition of neural excitation. When
excitation is sufficiently strong and the electrical charge in the neuron reaches a threshold
of positive intracellular charge, many neurons generate action potentials, and in immature
neurons GABA-induced Cl- efflux can be sufficient to cause action potentials. Action
potentials are what conduct electrical signals long distances in the nervous system, such
as from one brain area to another, so when GABA is excitatory due to high intracellular
Cl- that does not affect just the neuron responding to GABA, because GABA-induced
action potentials in those neurons are conducted to downstream connected brain areas.
This state of heightened electrical excitability may be adaptive in immature neurons

DOES BISPHENOL-A DISRUPT EXPRESSION OF THE NEURONAL KCC2?

4

because activity is important for brain development (Watanabe et al., 2019).
In later stages of development, neurons begin to increase expression of Clexporters (the KCC2 protein), and to decrease expression of Cl- importers (NKCC1),
which together drive down intracellular Cl- concentration from about 20µM to about
4mM (Watanabe et al., 2019). This switches the direction of the diffusion force on Cl- so
that GABA signaling induces Cl- inflow, which is inhibitory. These developmental
dynamics in Cl- transporter expression (increased KCC2, decreased NKCC1) are a
normal part of development, and is essential for GABA to transition from excitatory to
inhibitory at the right time in development (Figure 1).
Disruption in these processes of Cl- regulation is linked to neurological symptoms
(Cellot & Cherubini, 2014; Tang, 2020; Watanabe et al., 2019). For example, in human
idiopathic epilepsy there is a downregulation of KCC2 (Duy et al., 2019). In mouse
models, complete knockout of the KCC2 gene results in fatality immediately after birth
due to respiratory complications and grievous motor dysfunctions, while less extreme
deficiencies in KCC2 activity results in neural network hyperexcitability and
neurobehavioral disorders including autism-like and seizure-like symptoms (Hübner et al
2001; Tang, 2020; Merner et al., 2015; Kaila et al., 2014). Increasing levels of KCC2, in
contrast, can be an effective treatment for epileptic seizures and other disorders of neural
hyperactivity including neuropathic pain, and Rett syndrome (Tang, 2020; Cellot &
Cherubini, 2014). Rett syndrome is a neurodevelopmental disorder found in the autism
spectrum disorder and these individuals suffer from seizures, intellectual disability (Tang
et al., 2016), a decline in motor skills, and respiratory problems (Tang, 2020). In animal
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models of Rett and autism, and in human patients, decreasing activity of the Cl- importer
NKCC1 with the drug bumetanide (which has the same effect on cellular Cl- balance as
increasing KCC2), can reduce autism and epilepsy symptoms (Holmes et al.,2015;
Lemonnier et al., 2012). Together these findings underscore the harm of Cldysregulation and the potential therapeutic benefits of safe ways to control intracellular
Cl- levels through Cl- transporters. This study focuses on KCC2 since it is a neuronspecific protein and therefore a reasonable suspect in distinctly neurological syndromes
such as autism.
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Figure 1
Ion flow in immature and mature neurons

Note. In Figure 1A: Immature neurons in the central nervous system predominantly
express NKCC1, a Cl- importer, compared to KCC2, a Cl- exporter. When GABA
signaling occurs, it leads to the opening of Cl- channels, leading to the diffusion of Clions out of the cell down its concentration gradient. The efflux of negatively charged Clions results in the neuron’s intracellular space being more positive than the extracellular
space. The outflow of Cl- causes the cell to depolarize and reach the threshold of
excitation to send an action potential, resulting in a neural excitation. Figure 1B: Mature
neurons in the central nervous system have an upregulation of KCC2 and a
downregulation of NKCC1, a Cl- importer. When GABA signaling occurs, it leads to the
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opening of Cl- channels, leading to an influx of negatively charged Cl- ions in the
neuron. The influx of Cl- ion leads to the intracellular space being more negatively
compared to the extracellular space, thus causing hyperpolarization.

Multiple functions of Cl- Exporter, KCC2, in Development
KCC2 is a protein that has multiple functions during development. In mice
development, during the first two postnatal weeks, there is an increase of KCC2, a Cl- ion
exporter in the hippocampus (Virtanen et al., 2021). The steep increase in KCC2 results
in the GABA Cl- shift from excitatory to inhibitory but has other functions in developing
neurons as well. Specifically, KCC2 is known to have an anti-apoptosis function, control
aspects of neuron migration, and promote synapse formation (synaptogenesis) when
neurons stop migrating and begin integrating into circuits. These alternative functions of
KCC2 are briefly elaborated on below.
KCC2 has been shown to have an antiapoptotic role during prenatal development
of the mouse neocortex (Virtanen et al., 2021). Apoptosis is the process of programmed
cell death, which occurs in several phases during brain development as is a normal part of
eliminating excess or damaged neurons. Mavrovic et al., 2020, created knockout KCC2
mice and observed a significant decrease in neurons after 2 days. This, along with
supporting studies, was interpreted as suggesting that KCC2 normally protects neurons
against elimination by apoptosis. KCC2 knockout in mice also altered the migration
pattern of newly born neurons, suggesting that under normal conditions KCC2
upregulation is needed by neurons as a signal to stop migrating and begin forming
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synapses (Virtanen et al., 2021). Lastly, KCC2 has a role in synaptogenesis. Researchers
investigated whether a depletion or overexpression of KCC2 would have adverse effects
on the formation of synapsis. In one study KCC2 knockdown was shown to alter the
morphology of dendritic spines, which are post synapse structures that form on certain
neurons (Virtanen et al., 2021).

Bisphenol A
Bisphenol A (BPA) is a ubiquitous organic compound, it has been found in
consumer products such as water bottles, medical equipment, food containers (Liang et
al., 2018; Yeo et al., 2013; Weber et al., 2015), thermal paper, baby bottles and dental
sealants (Liang et al., 2018; Yeo et al., 2013; Xu et al., 2014). In addition, BPA was
detected in meat products and canned food (Weber et al., 2015). In addition, BPA is
known to be an endocrine disruptor (Xu et al., 2010, Kinch et al., 2015, Yang et al.,
2018). BPA has the ability to mimic endogenous estrogen and bind to estrogen receptors
(Yoon et al., 2014) as well as thyroid, androgen receptors, and estrogen-related receptors
(Kinch et al., 2015). These are all nuclear receptors, meaning their effects are mediated
by changes in gene expression, so the mechanism of BPA’s effects, while largely still
unknown, are also believed to involve changes in gene expression. Since estrogen is
known to influence early development and BPA as a mimicking molecule, BPA itself
would appear to have the potential to alter the development processes. In addition,
estradiol is known to regulate Dickkopf 1 (Dkk1) which is known to activate and inhibit
the Wnt signaling pathway. An increase in Dkk1 results in the inhibition of the Wnt
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signaling pathway. However, estradiol is able to downregulate Dkk1 resulting in the
activation of the Wnt signaling pathway and the transcription of β-catenin (Arevalo et al.,
2015).
Since humans are constantly exposed to BPA it is essential to determine the
adverse effects it has on neurodevelopment. The effects that BPA has on development are
not completely understood. Researchers associated the exposure of BPA to increase
dendritic spines and synapses (Yang et al., 2018; Xu et al., 2014). The result that BPA
increases synapse formation seems to conflict with the finding that BPA exposure also
decreases KCC2 expression in neurons (Yeo et al., 2013), because, as reviewed
previously, KCC2 knockout in mice decreases (as opposed to increases) synapse
formation (Virtanen et al., 2021). This discrepancy highlights the need for more research
on BPA’s neurodevelopmental effects.
In neurodevelopment is it important for the brain to develop normally to avoid
neurological disorders. There are studies that indicate BPA exposure is harmful to fetal
brains during development (Nishikawa et al., 2010). In one study, exposing mice to
100nM of BPA did not result in the elimination of the GABA Cl- shift. However, there
was a delay in the GABA Cl- shift which resulted in a significant decrease in KCC2/kcc2
mRNA expression (Yeo et al., 2013). Also, the exposure of BPA to pregnant mice
resulted in a downregulation of KCC2 mRNA in utero (Yeo et al., 2013). Moreover, BPA
exposure can affect neuronal function and development by interfering with gene
regulation. Another study found BPA exposure during fetal development may be harmful
to the fetus. In the brain, BPA inhibits cell proliferation through inhibition of the Wnt/B-
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catenin signaling pathway (Tiwari et al., 2015). In some cases, exposure to BPA has been
associated with neurodevelopmental disorders (Murata & Kang, 2018).
During development, BPA has shown different effects on neurogenesis in the
brain. In an in vitro experiment, the hippocampus was exposed to different concentrations
of BPA. At 10-100mM of BPA, there was an increase in dendritic spines, spinogenesis,
and synaptogenesis (Yang et al., 2018). In addition, Xu et al. 2014 found after 24 hours
of exposing BPA, there was an increase in dendritic length, motility, the dendritic density
of the hippocampus neuronal cultures, and an increase in N-methyl-D-aspartate (NMDA)
receptors. BPA has been theorized to be associated with neuronal growth (Xu et al.,
2014; Kinch et al., 2015). In addition, BPA is known to disrupt the wnt/ β-catenin
pathway resulting in a significant decrease in neural stem cell proliferation and
differentiation. In cultured neurons, BPA at doses lower than 10µM BPA enhances
proliferation in the neural stem cells however doses higher than 100µM promote
apoptosis. (Tiwari et al., 2015).

Zebrafish model organism
Zebrafish (Danio rerio) are commonly used as a model organism in biology
research. These small tropic fish are used to study neurological disorders and human
diseases. Zebrafish embryos facilitate research because they are translucent and develop
rapidly. As zebrafish develop, the embryos are translucent which facilitates and enables
non-invasive and detailed characterization of embryonic phenotypes (Santoriello & Zon,
2012). Besides being translucent and developing rapidly, zebrafish genes have high level
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of functional conservation, having a 76% sequence overlap with the human genome
(Howe et al., 2013). Consequently, zebrafish make a useful model organism for studying
human diseases or neurological disorders since the zebrafish neuroanatomical and
neurochemical pathways are similar to humans (Lucini et al., 2018). Lastly, zebrafish and
humans have similar brain structures such as the medulla, cerebellum, and hypothalamus
(Howe, 2013). In addition, the zebrafish pallium has a role in the control of sensory and
motor autonomic function (Ganz et al., 2014). Furthermore, the pallium is homologous to
the mammalian hippocampus, which is an area where seizures initiate (Podlasz et al.,
2018). The mammalian hippocampus and the zebrafish pallium are rich in galanin
protein, and a decrease in galanin protein have been found in mammals with epileptic
seizure (Podlasz et al., 2018). Therefore, zebrafish can be used to research human
neurological diseases (Ganz et al., 2014).
Bisphenol A has been shown to affect neurodevelopment in zebrafish. During
hypothalamus development, zebrafish undergo neural differentiation between 18 hours
post-fertilization (hpf) to 36 hpf and by 48 hpf most brain structures have developed
(Kinch et al., 2015). BPA is known to promote neurogenesis in the hypothalamus. Kinch
et al., 2015 exposed zebrafish larvae to 0.0068µM BPA from 0-5 dpf. Those that were
exposed to BPA from 0-5 dpf showed significantly greater quantities of new neurons in
the hypothalamus compared to the control group. In another experiment, a low dose
exposure of BPA (0.01µM), in line with environmental exposure levels, led to learning
deficits in adult zebrafish and hyperactivity in larval zebrafish (Saili et al., 2012). The
fact that BPA affects zebrafish brain development and behavior suggests that zebrafish
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can be useful in modeling the effects of BPA on these processes in humans. Specifically,
studies in zebrafish could reveal whether any of these effects of BPA are mediated
through effects on the Cl- exporter, KCC2.
Galanopoulou & Moshé 2003, investigated whether KCC2mRNA is regulated by
sex hormones, which is relevant to BPA since it is an estrogen mimicking compound.
The researchers analyzed substantia nigra reticulate (SNR) neurons in male and female
rodents on postnatal day 15 (PN15). The results showed male PN15 rodents had an
increase in KCC2mRNA expression after being exposed to testosterone and
dihydrotestosterone (Galanopoulou & Moshé 2003). Interestingly, females also
demonstrated a significant increase in KCC2mRNA expression after being exposed to
testosterone. However, when male and female PN15 rodents were exposed to 17 βEstradiol there was a downregulation of KCC2mRNA expression in SNR in males
compared to females (Galanopoulou & Moshé 2003). The sex difference that occurred is
hypothesized to be due to the sexual dimorphic GABAA receptor signing pathway
(Galanopoulou & Moshé 2003). In this current study, larval zebrafish will be used to
examine the effects of BPA on KCC2 expression. Since there is no major chromosomal
sex-determining locus in the zebrafish genome, sex of larvae cannot be determined and
these sex effects on the regulation of KCC2, while clearly important in rodents, will not
be examined in the current study (Kossack & Draper, 2019).
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Statement of the Problem

Bisphenol A (BPA) is a widespread toxin that may disrupt neurodevelopment
processes normally controlled by estrogen. Potassium-chloride cotransporter 2 (KCC2)
has an essential role in early development. KCC2 is a neuron-specific Cl- ion exporter
that strongly influences the electrical excitability of neurons, with more KCC2 associated
with more inhibition, and suppression of KCC2 associated with brain hyperexcitability
and neurological disorders. Since estrogen has been shown to suppress KCC2 gene
expression, it is possible that BPA can also suppress KCC2 and contributes to the risk for
disorders of brain hyperexcitability including autism and epilepsy. Therefore, it is
important to determine whether BPA affects KCC2 expression. The basic experimental
strategy was to expose zebrafish embryos to BPA and measure KCC2 expression. KCC2
expression will be measured in two ways. One way is a novel transgenic zebrafish line
(KKC2:mCitrine) in which a fluorescent protein (mCitrine) is expressed under the control
of the KCC2 gene promotor, theoretically allowing KCC2 expression to be measured as
fluorescence brightness using a fluorescence microscope. However, since that method of
assessing KCC2 expression is not validated, reverse transcriptase-quantitative
polymerase chain reaction (RT-qPCR) will be used as a secondary method of assessing
KCC2 expression level.
In addition, BPA has been associated with anxiety-like behavior and epilepsy and
this experiment also sought to examine locomotor activity. If BPA treated zebrafish
embryos had a significant decrease in KCC2 expression then it would result in an
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inhibitory/excitatory imbalance, leading to spontaneous locomotor activity (i.e.
hyperactivity bursts). The spontaneous locomotor activity would be indicative of anxietylike behavior. A behavioral assay was conducted to demonstrate whether BPA exposure
during early development would result in spontaneous locomotor activity due to the
decrease of KCC2.
A positive control was used in this experiment. Estrogen has been known to
regulate several developmental processes by estrogen receptors (ERs), which regulate
transcription factors that regulate CYP19a1b. BPA has been thought to have
epileptogenic suppression of KCC2mRNA by its ability to weakly mimic estrogen.
Therefore, by using exposing BPA to a transgenic CYP19a1b zebrafish line there would
result in an increase in CYP19a1b.
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Hypotheses

Hypothesis 1: Zebrafish embryos exposed to 2.5µM BPA from 8 hours post-fertilization
(hpf) – 6 days post-fertilization (dpf) will significantly decrease KCC2-linked
fluorescence brightness in neurons, especially in the pallium and the whole brain in
KCC2:mCitrine zebrafish, compared to sibling control larvae raised in regular water.

Hypothesis 2: A secondary measurement, RT-qPCR, was used to validate transgenic
fluorescence measurement. Zebrafish embryos exposed to 2.5µM BPA from 8hpf– 6dpf
will show a decrease in KCC2mRNA expression compared to their sibling control.

Hypothesis 3: Zebrafish KCC2:mCitrine transgenic line embryos exposed to 2.5µM
BPA from 8hpf – 6dpf will demonstrate significantly higher behavioral activity at 7dpf
compared to their control siblings’ larvae raised in water.

Hypothesis 4: Zebrafish embryos treated with 2.5µM BPA from 5hpf – 7dpf will
increase CYP19a1b (brain aromatase) enzyme expression in neurons compared to their
sibling control.

Rationale for Hypothesis 1-4. Previous studies have shown that this BPA exposure
protocol in zebrafish (equivalent dose and exposure timing) affects the rate of
neurogenesis in the hypothalamus and increases locomotor activity levels in larval
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zebrafish. BPA has also been shown to directly suppress KCC2 expression in cultured
neurons and rodent brains. Therefore, it is plausible that one of the effects of BPA in
developing zebrafish brain is the suppression of KCC2 expression. Low levels of KCC2
expression is associated with neurological disorders in humans, so it is important to
understand factors that could suppress KCC2. BPA is potentially one such factor. It is an
industrial waste product present in the environment and in human bodies. Although toxic
effects of BPA in humans has been of concern for many years, KCC2 suppression is a
recent hypothesis for the mechanism of BPA toxicity. Our lab recently generated a
transgenic zebrafish with fluorescence in neurons linked to KCC2 expression. This is a
novel and unvalidated method for measuring dynamic changes in KCC2 expression
during development. Therefore, a secondary method for measuring KCC2 expression is
proposed, RT-qPCR, which measures KCC2mRNA copy and should be sensitive to any
BPA-induced changes in expression level. This study is thus designed both to measure
BPA effects on KCC2 expression and to validate our new transgenic fluorescence-based
readout of KCC2 expression. Lastly, estrogen has been known to regulate several
developmental processes by ERs, which regulate CYP19a1b. In addition, CYP19a1b has
been known to be sensitive to estrogen levels.
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Methods

Subjects
This study was conducted under the approval of the Institution Animal are and
Use Committee (IACUC) protocol. Adult male and female KCC2:mCritrine zebrafish
were placed in a tank for mating in order to collect embryos for the study.

Drug Dosage
The treatment solutions were dissolved in egg water and pH'd to ~7.2. There were
two solutions, BPA at 2.5µM and control. Since BPA requires 0.01% of the solvent,
dimethyl sulfate (DMSO), to go into aqueous solution, the control solution also contained
0.01% DMSO.

Experimental Design
Adult zebrafish KCC2:mCitrine females and males were removed from their
home tanks and placed into a 1-liter mating tank. The mating tank contained a plastic
divider separating female and male KCC2:mCitrine zebrafish. On the next day, the
plastic divider was removed, and then I checked every 30-minute interval for fertilized
eggs. All 8hpf fertilized eggs were removed and rinsed using a suction pipette and placed
into petri dishes. Each petri dish contained 20mL of the treatment solution (2.5µM BPA
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or 0.01% DMSO) and a maximum of 50 larvae. Afterward, the petri dish containing the
larvae was placed in an incubator at 27 degrees Celsius, developing for 20 hours.
Every day the treatment solution was replaced, and dead embryos were removed
and discarded using a suction pipette. The same embryos were measured repeatedly over
time for a within subject analysis. Individual embryos were separated in separate wells
of a 24well tissue culture plate and returned to the same well after each imaging point,
allowing tracking of the same individual embryos over time. The imaging setting for the
epifluorescence camera and confocal were kept constant across brains within each time
point.

BPA effects on KCC2:mCitrine expression
KCC2:mCitrine embryos (N = 48) were randomly selected from the clutch. BPA
(n = 24) and control (n = 24) zebrafish embryos were placed in two separate 24well tissue
culture plates. Starting at 2dpf, fluorescence scans were taken to capture KCC2-linked
mCitrine fluorescence from neurons. At 2dpf and 4dpf each embryo was placed on a
coverslip for epifluorescence imaging. The embryos were positioned on the ventral side
to capture a ventral view of the brain using the epifluorescence camera. The 2dpf
embryos (N = 48) were not anesthetized because they were still and easy to manipulate
their orientation to capture an image. At 3dpf, a control zebrafish embryo died so it was
not used for imaging. At 4dpf, the control (n = 23) and BPA (n = 24) treated embryos had
already hatched from their egg and had to be anesthetized to capture a still image. All
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images captured at 2dpf and 4dpf were in 8bit grayscale with pixel brightness intensity
ranging from 0-255.
A BPA treated larvae died, so no data was obtained from the larvae. At 6dpf, the
BPA (n = 23) and control (n = 23) larvae were anesthetized and embedded in agar for
confocal imaging. Confocal images were captured in 16bit format with pixel brightness
intensity ranging from 0-65,536. A series of 31 images were obtained through the dorsalventral axis of the brain, with 8µm steps between images. The start point of each depth
series, at the dorsal surface of the brain, was determined by getting a clear view of the
skin pigmentation on the zebrafish’s dorsal surface. Individual embryos underwent
~20min of fluorescence imaging before being returned to their home dish of egg water in
the incubator. After completing planned imaging time points, embryos were euthanized
by rapid chilling in accordance with the IACUC-approved procedures.
The epifluorescence and confocal images were analyzed using ImageJ to
determine the intensity of KCC2:mCitrine fluorescence. The confocal images captured at
16bit were transformed to 8bit to allow direct comparison to the 8bit epifluorescence
images. Furthermore, slices 3-31 were used from the confocal images because they
captured the whole brain. Then the images were cropped and rotated so that the sagittal
midline lined up as straight as possible (Figure 2A). Then a montage (Figure 3) was made
to aid in determining a region of interest (ROI) from which to quantify fluorescence
brightness. After looking at the montage, it showed that the ROI should be around the
pallium because it was free of pigment and visible in all specimens. An ROI was created
and placed above the horizontal sulcus and most lateral on the right side to capture the
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pallium (Figure 2B). The left pallium was used when the pigment was covering the right
side of the pallium. In addition, another ROI was created to capture the whole zebrafish
brain. ROI size and shape were kept consistent across brains. Lastly, attempts were made
to adjust image brightness to normalize background brightness across specimens, but it
was determined that this correction did not affect the outcome of statistical tests, so that
effort was dropped and only data from uncorrected images are presented.
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Figure 2
A whole brain confocal image at 6dpf zebrafish larva

Note. Each image is a projection of 29 images taken through the dorsal-ventral axis of the
brain. Figure 2A demonstrates how the images that were obtained were cropped, rotated,
and lined up. Figure 2B shows one example of an ROI that was created to capture the
pallium.
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Figure 3
A 6dpf zebrafish brain montage

Note. The confocal images were used to create a montage. The images were captures at
6dpf for BPA treated and control group.

RNA extraction and RT-qPCR
A secondary method for measuring KCC2 gene expression level was RT-qPCR,
which measures KCC2mRNA copy number and was expected to be sensitive to any
BPA-induced changes in expression level. Embryos were collected and treated as
described above for fluorescence measurements. Following BPA or control treatment,
embryos were euthanized by rapid chilling in ice, and processed in the RT-qPCR
procedure, which is outlined in detail in the QuantiNova SYBR Green RT-PCR protocol.
RT-qPCR determines the starting amount of mRNA of a target transcript (KCC2 in our
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case) by measuring how many DNA amplification cycles (temperature cycles in which
DNA is copied/amplified once each cycle) are required to reach a set amplification level,
a measurement referred to as the Cq index. Two standard baseline zebrafish genes were
used, elf-alpha and rpl13, which, as controls, were expected to have similar levels of
amplification across conditions. In addition, primers were designed to target and amplify
the KCC2b gene. In this experiment, the Quick-RNA Miniprep Kit was used for RNA
extraction, and the QuantiNova SYBR Green RT-PCR kit for RT-qPCR.

BPA effects on CYP 19 expression
CYP19a1b:GFP embryos (N = 24) were randomly selected for this positive
control experiment. CYP19a1b:GFP embryos (n = 12) were collected and treated with
BPA as described above for KCC2:mCitrine embryos used in fluorescence
measurements. A BPA treated larvae died, so it was not used for imaging. At 7dpf,
CYP19a1b larvae were anesthetized and embedded in agar for confocal imaging. The
confocal setting was set at 16bit and the depth stack captured 31 slices at every 5µm
moving dorsal to ventral. The start point was determined by getting a clear view of the
skin pigmentation on the zebrafish’s dorsal surface. Eleven BPA and twelve control
zebrafish larvae underwent imaging. After all the images were collected, slices 4-31 were
used because they captured most of the green fluorescent protein (GFP) expression from
the brain. The slices were combined using the maximum brightness projection method to
make a single image which was then cropped and rotated to normalize orientation across
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brains. An ROI was created (seen in Figure 4) to capture the midline because that was
where CYP19a1b:GFP was highly expressed.

Figure 4
ROI capturing CYP19a1b expression at 7dpf

Note. This is a maximum projection of 27 confocal images through the dorsal-ventral axis
of the brain showing CYP19a1b:GFP fluorescence in the brains of 7dpf zebrafish larvae.

BPA effects on CYP 19 locomotor activity
At 7dpf, the BPA treated (n = 24) and control (n = 24) zebrafish were used in a
behavioral assay to measure locomotor activity. In this locomotor behavioral assay, 24
BPA treated and 24 control zebrafish were placed in two 24 well plates (see Figure 5).
The camera was positioned to capture both plates and two lightbulbs were placed on each
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side for even illumination of the imaging field. DAQFactory was used to create a series
of codes to control the camera. The recording block duration was set at 300sec (5mins),
at 1 second per frame, then stop recording for 3300sec (55min). The series of codes was
set to record for a total of 1,800 seconds (30 minutes) for a span of 6 hours. The goal was
to capture a representative sample of behavioral activity by recording for 5 minutes per
hour for 6 hours. After the completion of the 6 hours, the camera was programmed to
stop recording.
Figure 5
Larvae exposed to BPA and the control solution were placed in individual wells for the
recording of spontaneous swimming activity.

Note. Example of spontaneous swimming activity in 7-day old BPA-treated larvae (left
plate) and control larvae (right plate). The image shows an overlay of a single
unprocessed video frame in gray, and in red a projection of 300 video frames taken at a
rate of 1 frame per second, spanning 5 minutes.
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Results

KCC2:mCitrine brightness in the pallium (Hypothesis 1)
This analysis attempted to examine whether there was a statistically significant
difference in KCC2:mCitrine fluorescence intensity in the zebrafish pallium. A mixed
model ANOVA was conducted to determine if there was a statistically significant
difference in KCC2:mCitrine fluorescence brightness in the pallium of zebrafish embryos
exposed to 2.5µM BPA versus their sibling control larvae raised in regular water with
0.01% DMSO over the course of 2, 4, and 6dpf. There was no violation in sphericity, and
the results indicated there was a main effect for time (age), 2dpf (M = 124.39, SD =
34.47), 4dpf (M = 167.52, SD = 37.04), and 6dpf (M = 280.73, SD = 107.66), F(2, 88) =
73.98, p < .001, ges = .49. There was no main effect for BPA treatment (M = 177.90, SD
= 102.13, and M = 203.85, SD = 86.09), for BPA and control groups, respectively, F(1,
44) = 4.03, p = .05, ges = .04. These main effects were not qualified by a significant
interaction, F(2, 88) = .39, p = .06, ges = .005 (shown in Table 1). A series of paired ttests were conducted and showed that at 2dpf, BPA (M = 115.10, SD = 34.74) treated
embryos showed a significant difference in KCC2 brightness compared to 4dpf (M =
147.75, SD = 32.06), t(22) = 4.1, p < .001, d = .98. At 4dpf, BPA treated embryos
showed significantly less KCC2 brightness expression compared to 6dpf (M = 270.86,
SD = 126.09), t(22) = 4.8, p < .001, d = 1.01. When looking at the control group the
paired t-tests showed a significant increase in KCC2 brightness from 2dpf (M = 133.69,
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SD = 32.29) to 4dpf (M = 187.29, SD = 31.02), t(22) = 5.2, p < .001, d = 1.08, and from
4dpf to 6dpf (M = 290.60, SD = 87.22), t(22) = 5.38, p < .001, d = 1.12. In addition, a
series of one-tail independent samples t-tests were conducted and demonstrated that at
2dpf BPA treated embryos (M = 115.10, SD = 34.74), had significantly less KCC2
expression than their control siblings (M = 133.69, SD = 32.29), t(44) = 1.9, p = .03, d =
0.55. Embryos at 4dpf treated with BPA (M = 147.75, SD = 32.06) had significantly less
KCC2 brightness compared to the control (M = 187.29, SD = 31.01), t(44) = 4.25, p <
.001, d = 1.25. However at 6dpf embryos exposed to 2.5µM BPA (M = 270.86, SD =
126.09) had no significant difference in KCC2 brightness compared to the control (M =
290.59, SD = 87.22), t(44) = .62, p = .27, d = .18 (Figure 6).
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Figure 6
KCC2 Fluorescence Intensity in the Pallium

Note. The graph depicts that at 2dpf and 4dpf the control group had more KCC2:mCitrine
fluorescence intensity in the pallium compared to the BPA treated larvae. However at
6dpf there was no significant difference in KCC2:mCitrine fluorescence intensity in the
pallium between the control and BPA treated larvae. Lastly, there was a steep increase
from 4dpf to 6dpf, consistent with the ‘GABA switch’ hypothesis of delayed
upregulation of KCC2 expression.
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Table 1.
KCC2 fluorescence intensity in the Pallium
Effect
Treatment
Time
Treatment : Time

SS
23242.4
599770.8
3189.4

df
1
2
2

MS
23242.4
299885.4
1594.7

F
4.0
73.9**
0.4

Note. ** p < .001. No sphericity adjustments were made. The table shows the main
effects and age x treatment interaction of KCC2 fluorescence intensity in the pallium.
There was no significant effect in treatment, however, there was a significant difference
in time (age). These main effects were not qualified by a significant interaction.

KCC2:mCitrine brightness for the whole brain (Hypothesis 1)
This second analysis used a mixed model ANOVA to examine whether
KCC2:mCitrine fluorescence intensity measured across the entire brain was statistically
different across ages or treatment conditions. A preliminary analysis showed there was no
violation in sphericity. A mixed model ANOVA determined there were there was a
statistically significant effect in treatment, BPA (M = 145.50, SD = 35.96) and control (M
= 157.82, SD = 39.19), F(1, 44) = 5.60, p = .02, ges = .05. There was also a main effect in
time (age), for 2dpf (M = 140.52, SD = 9.07), 4dpf (M = 126.88, SD = 10.99), and 6dpf
(M = 187.57, SD = 45.99), F(2, 88) = 80.40, p < .001, ges = .50. These main effects were
qualified by a statistically significant interactions, F(2, 88) = 5.91, p = .003, ges = .07
(shown in Table 2). A series of paired t-tests were conducted to look at KCC2:mCitrine
brightness intensity for the whole brain over time for the control and BPA treated larvae.

DOES BISPHENOL-A DISRUPT EXPRESSION OF THE NEURONAL KCC2?

30

A paired t-test showed at 2dpf, BPA (M = 140.19, SD = 9.00) treated embryos had
significantly lower KCC2:mCitrine brightness compared to 4dpf (M = 124.80, SD =
11.55), t(22) = 7.1, p < .001, d = 1.48. When comparing 4dpf to 6dpf (M = 171.47, SD =
50.97), t(22) = 3.1, p = .005, d = .86 there was a significant increase in KCC2:mCitrine
brightness intensity. When looking at KCC2:mCitrine brightness intensity of the whole
brain over time in the control group a paired t-test showed that 2dpf (M = 140.84, SD =
9.33) had a significantly lower KCC2:mCitrine brightness compared to 4dpf (M =
128.96, SD = 10.22), t(22) = 5.4, p < .001, d = 1.41. Lastly, when comparing 4dpf to 6dpf
(M = 203.66, SD = 34.46), t(22) = 11.8, p < .001, d = 2.94 there was a significant increase
in brightness intensity. In addition, a series of one-tail independent samples t-tests were
conducted to determine if there was a significant difference in the KCC2:mCitrine
brightness for the whole brain in BPA treated embryos over time. A one-tail independent
t-test at 2dpf demonstrated that BPA (M = 140.19, SD = 9.00) did not differ in KCC2
brightness intensity from the control (M = 140.84, SD = 9.33), t(44) = .24, p = .41, d =
.07. At 4dpf there was no significant difference in KCC2 brightness intensity between
BPA (M = 124.80, SD = 11.55) and control (M = 128.96, SD = 10.22), t(44) = 1.29, p =
.10, d = .38. At 6dpf KCC2:mCitrine brightness was significantly lower in zebrafish
larvae that were treated with BPA (M = 171.49, SD = 50.97) compared to the sibling
controls (M = 203.66, SD = 34.46), t(44) = 2.51, p = .008, d = .74 (Figure 7).
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Figure 7
KCC2:mCitrine Brightness for the Whole Brain from 2dpf to 6dpf

Note. A 2dpf and 4dpf there was not a significant difference in KCC2:mCitrine
brightness intensity between the BPA treated zebrafish larvae and their sibling control. At
6dpf the zebrafish larvae control showed higher KCC2:mCitrine brightness intensity
compared to the BPA treated larvae.
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Table 2
KCC2 fluorescence intensity for the whole larvae brain
Effect
SS
df
MS
F
Treatment
5239.4
1
5239.4
5.6*
Time
93288.2
2
46644.1
80.4**
Treatment : Time 6860.3
2
3430.2
5.9*
Note. * p < .05, ** p < .001. No sphericity adjustments were made. The table shows the
main effects and age x treatment interaction of KCC2 fluorescence intensity in the whole
brain. The exposure of BPA did decrease KCC2:mCitrine brightness intensity compared
to the BPA group over time. There was a significant main effect in treatment, time (age),
and treatment x time (age) interaction.

RT- qPCR, quantifying KCC2mRNA (Hypothesis 2)
Two runs of the RT-qPCR experiment were conducted, on 2/26/2022 and
3/16/2022. Unfortunately, the data to date are equivocal. The primary measurement in
RT-qPCR is called a cQ value, which is a measure of how much target cDNA has been
amplified, which is dependent on the starting amount of mRNA in the sample from which
the cDNA was made. cQ values, as a measure of the starting amount of target mRNA, is
an estimate of the level of transcription of the gene of interest. I was primarily interested
in the amount of KCC2b mRNA. However, cQ values for target genes must be
interpreted relative to a baseline gene that is expected to have stable expression
regardless of the experimental manipulation (in this case, BPA exposure). I used two
standard baseline genes for zebrafish, elf-alpha and rpl13, which, as controls, were
expected to show similar levels of amplification across conditions. On the first attempt,
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only 4 out of 80 reaction wells that were expected to show amplification did, meaning the
PCR machine did not produce a cQ value for 76 samples. This included 4 baseline gene
samples that were expected to amplify, strongly suggesting technical problems with the
experiment. The suspected problem was an insufficient concentration of RNA in the
original sample because nanodrop readings of RNA concentration showed marginal
concentrations (below 90ng/ml) for some samples. In the second run, a different RNA
extraction procedure was used, and higher RNA concentrations were recorded (all above
90ng/ml). However, no amplification was detected in any of the PCR reactions,
suggesting a different technical problem. Therefore, no conclusions can be drawn from
these RT-qPCR experiments.

BPA effects on locomotor activity (Hypothesis 3)
A stacked image capturing locomotor activity was obtained across 6 hours, with 5
minutes sampled per hour using a video rate of one frame per second (shown in Figure
8). A one-tailed Independent Samples T-test was conducted to determine if zebrafish
embryos exposed to 2.5 µM BPA showed the expected increase in spontaneous
locomotor activity compared to the control group. The analysis indicated BPA treated
zebrafish (M = .36, SD = .18) did not significantly differ in locomotor activity compared
to their control siblings raised in 0.01% DMSO (M = .42, SD = .22), t = .98, p = .16, d =
.28 (Figure 9).
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Figure 8
A Stack image capturing locomotor activity

Note. The stack image shows the locomotor activity across 6 hours, with 5 minutes
sampled per hour using a video rate of one frame per second. Wells in the left 4 columns
contain BPA-treated larvae and the right 4 columns are the controls.
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Figure 9
Locomotor activity at 7dpf in BPA and control zebrafish larvae.

Note. Zebrafish larvae treated with BPA from 8hpf to 7dpf or with 0.01% DMSO (control
group) had no difference in locomotor activity that is indicative of hyperactivity. Error
bars show the standard deviation of the mean.

BPA effects on CYP 19 expression (Hypothesis 4)
A one-tailed independent t-test was conducted to determine if there was a
statistically significant brightness intensity increase in CYP19a1b:GFP after BPA
treatment compared to the control. Zebrafish embryos exposed to BPA (M = 522.99, S =
99.09) had a statistically significant higher CYP19a1b fluorescence intensity compared to
their sibling control (M = 425.62, S = 55.32), t = 2.94, p = .004, d = 1.23. In other words,
zebrafish exposed to 2.5µM BPA showed more fluorescence indicating more CYP19a1b
compared to their sibling control raised in water (Figure 10).
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CYP19a1b brightness intensity observed at 7dpf

Note. At 7dpf, there was higher CYP19a1b brightness indicating more CYP19a1b
expression in zebrafish larvae treated with BPA as opposed to the control group.
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Discussion

Bisphenol A is widely found in various customer products. BPA acts as a weak
estrogen analog and therefore it is able to mimic estrogen’s actions on receptors. Since
estrogen influences early brain development, this study attempted to determine if
exposure to BPA would downregulate KCC2 expression in zebrafish as shown previously
in cell culture (Yeo et al., 2013). A downregulation in KCC2 has been associated with
hyperexcitability that is seen in patients with autism spectrum disorder and epilepsy.
These neurological disorders, and others, are characterized by increased synchronous
electrical activity in the brain. Epilepsy affects 1 in 200 people and about 70% of them
have no known cause (Sander & Shorvon, 1996; Fuller et al., 2018), raising the
possibility that KCC2 dysregulation could explain some cases of idiopathic disease.

BPA effects on KCC2 expression during development (Hypothesis 1)
The pallium is a part of the zebrafish telencephalon. The pallium has been
implicated to play a role in epilepsy due to the pallium having a role in the control of
sensory and motor autonomic function (Ganz et al., 2014). A previous study found the
zfhx3 gene to be implicated in epilepsy and from 2dpf to 3dpf zebrafish have high
amounts of zfhx3 expressed in the pallium (Fuller et al., 2018). A downregulation in the
zfhx3 resulted in seizure sensitivity. In this current experiment, zebrafish embryos were
exposed to 2.5µM BPA from 8hpf to 6dpf to determine if there was a decrease in KCC2
brightness which would indicate a downregulation in KCC2. The epifluorescence images
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taken at 2dpf and 4dpf show there was a decrease in KCC2 brightness intensity compared
to the control. However, at 6dpf the noticeable differences in KCC2 brightness intensity
between the BPA treated and their sibling controls were gone. This indicates the pallium
might be susceptible to BPA at an early stage of development as opposed to a later stage
in development. The gradual increase in KCC2 fluorescence brightness seen from 2dpf to
6dpf in BPA and control groups is consistent with the GABA switch hypothesis of a
delayed upregulation of KCC2 expression. A more noticeable steep increase in KCC2
fluorescence brightness was seen from 4dpf to 6dpf. These results are consistent with the
literature. Zhang and colleagues found that in zebrafish retinal ganglion cells the GABA
excitatory/inhibitory switch takes place at 2.5dpf (2010). The steep increase in KCC2
fluorescence was therefore likely a result of upregulation in KCC2. Although there were
no noticeable differences at 6dpf between BPA and control, it indicates that BPA has an
effect only during the early stages of development and pallial neurons are able to recover
from BPA exposure.
BPA exposure was also shown to decrease KCC2:mCitrine fluorescence when
analyzing the whole brain as opposed to just the pallium, although in that analysis the
effect was seen only in larvae aged 6dpf. These results are in agreement with previous
studies on the epigenetic suppression BPA has on KCC2. Exposure to BPA decreased
KCC2mRNA and therefore the synthesis of KCC2 protein (Yeo et al., 2013).
Furthermore, a decrease in KCC2 protein led to less Cl- ions being extruded out of the
cell, resulting in a Cl- imbalance and ultimately to neuronal hyper-excitability.
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Unfortunately, these results based on fluorescence measurements were not able to be
validated by RT-qPCR due to technical failures discussed earlier.

RT- qPCR, quantifying KCC2 mRNA (Hypothesis 2)
Reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR) is the
gold standard for measuring gene expression (Lan et al., 2009), and I set out to use this
method to test the external validity of our fluorescence brightness measures. In this study,
RT-qPCR was used to determine the amount of KCC2b mRNA in the BPA treated
zebrafish embryos and the control. On 2/26/2022 and 3/16/2022 two RT-qPCR
experiments were conducted. Unfortunately, both data were uninterpretable. In the first
RT-qPCR attempt, only 4 out of 80 reaction wells that were expected to show
amplification did, meaning the PCR machine did not produce a cQ value for 76 samples.
A possible technical issue was an insufficient concentration of RNA in the original
sample. In the second attempt, a different RNA extraction kit was used, and it produced
higher RNA concentrations. However, no amplification was detected in any of the PCR
reactions, suggesting there was a different technical problem. Our team consulted with
the PCR kit manufacturer, Qiagen, and they agreed to send us a new kit free of charge in
case our previous failure was caused by defects in the kit materials. Therefore, at this
time no results for the planned PCR experiments are available. Without the external
validation from RT-qPCR, the fluorescence measures cannot be relied on. There are
several external variables that affect reproducibility such as the thickness of the coverslip
and how the zebrafish were mounted in agar.
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BPA effects on locomotor activity (Hypothesis 3)
A downregulation in KCC2 has been associated with hyperexcitability in animal
models and in patients with epilepsy related to KCC2 dysfunction (Duy et al., 2019;
Hübner et al., 2001; Tang, 2020; Merner et al., 2015; Kaila et al., 2014). Seizures are
characterized by an increased and synchronous electrical activity in the brain due to an
excitatory/inhibitory imbalance. Therefore, a locomotor behavioral assay was conducted
because a decrease in KCC2 was expected to lead to an increase in spontaneous
locomotor activity in zebrafish larvae exposed to BPA. The locomotor behavioral assay
demonstrated that BPA-treated larvae did not exhibit spontaneous locomotor activity
compared to the control even though there was a significant downregulation in KCC2
expression in the entire brain. However, the pallium has a role in the control of sensory
and motor autonomic function (Ganz et al., 2014). Since there was no difference in
KCC2 fluorescence in pallium compared to the control, which indicated both groups had
roughly the same about of KCC2 protein. Hence, there was no difference in BPA-treated
larvae when looking at locomotor activity. However, due to the fact, that the RT-qPCR
was deemed equivocal there is no way to determine if the apparent difference in KCC2
expression was valid. The result obtained from the locomotor assay was in agreement
with the literature. In zebrafish, neurogenesis occurs between 16hpf to 36hpf, and Kinch
et al., 2015 exposed 0.1µM BPA zebrafish before and during neurogenesis occurs. Kinch
and colleagues found when zebrafish were treated with a low dose of BPA, they showed
an increase in locomotor activity when exposed at 16-24hpf and 24-36hpf but not when
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BPA was exposed before 10-16hpf (2015). In addition, the locomotor behavior was
recorded at 30 frames per second for 5 minutes in a dark setting following a resting 20minute period of exposure to light (Saili et al., 2012). An explanation for the results in
this current study is since zebrafish were exposed to BPA from 8hpf to 6dpf they were
able to recover and overcome the toxic exposure of BPA. A limitation was that locomotor
activity was recorded at 1 frame per second, and a possibility is that zebrafish larvae have
a quick locomotor behavior that cannot be detected at 1 frame per second.

BPA effects on CYP 19 expression (Hypothesis 4)
Adult zebrafish express high levels of CYP19a1b which is encoded by the
cyp19a1b gene. CYP19a1b is also expressed in a developing zebrafish brain and is
restricted to radial glial cells. In this current experiment, the effects of BPA on
CYP19a1b served as a positive control to demonstrate that BPA does penetrate the bloodbrain barrier, binds to estrogen receptors regulating gene expression, and has the ability
to affect early development. The results showed BPA does affect CYP19a1b expression.
Zebrafish embryos exposed to BPA from 5hpf to 7dpf showed higher levels of
CYP19a1b compared to their sibling control raised in water. These results indicated that
BPA does pass the blood-brain barrier and due to its estrogenic properties, it is able to
upregulate CYP19a1b. The data is consistent with previous studies. Mouriec et al., 2009
showed that the cyp19a1b gene is sensitive to estrogen and showed that cyp19a1b
expression is upregulated by estrogen. In addition, Kinch et al., 2015 confirmed that an
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upregulation of CYP19a1b expression is attributed to the metabolism of androgen to
estrogen which then activates estrogen receptor binding to cyp19a1b regulatory factors.

Study limitation and Future directions
There were several limitations in this series of experiments. First, sample size was
limited due to time and difficulty involved in preparing larvae for fluorescence imaging
and in performing the imaging. Second, the RT-qPCR methods did not work, and
therefore the observed changes in fluorescence could not be directly validated as
reflecting changes in KCC2 gene expression. Since our KCC2:mCitrine transgenic
fluorescence marker zebrafish are a novel tool, it is a priority to validate these
fluorescence measurements.
Aside from RT-qPCR, another validation approach is to test whether drugs known
to increase KCC2 expression also increase KCC2:mCitrine fluorescence brightness in our
zebrafish line. The neurohormone, brain derived neurotropic factors (BDNF) is known to
regulate KCC2 expression. BDNF has an essential role in early neurodevelopment such
as neuronal growth, differentiation, and has been implicated in plasticity and synaptic
function (De Felice et al., 2014). BDNF binds to its receptor Tyrosine receptor kinase B
(TrkB), which activates a series of signaling pathways that regulate KCC2 expression. In
immature neurons, BDNF upregulates KCC2 expression through a series of signaling
cascades. In immature neurons, the BDNF-TrkB, signaling MAP/ERK (MEK) and
extracellular signal-regular kinase 1/2 (ERK1/2) signaling pathway to increase Erg 4
expression (Lee-Hotta et al., 2019). An increase in the transcription factor Erg 4 leads to
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an increase in KCC2 expression and protein levels (Lee-Hotta et al., 2019). Therefore, if
BDNF has the potential to upregulate KCC2:mCitrine expression. Interestingly, there is
also evidence that BPA can inhibit Bdnf transcription (Kundakovic et al., 2014; Wang et
al., 2016).
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Conclusions

Downregulation of KCC2 during development can disrupt neuronal Cl- regulation
and lead to neurological symptoms (Cellot & Cherubini, 2014; Tang, 2020; Watanabe et
al., 2019). For instance, in humans, some cases of idiopathic epilepsy result from the
KCC2 dysregulation (Duy et al., 2019). Previous studies have shown, in mouse models,
that complete knockout of the KCC2 gene results in fatality immediately after birth due
to respiratory complications and grievous motor dysfunctions, while less extreme
deficiencies in KCC2 activity result in neural network hyperexcitability and
neurobehavioral disorders including autism-like and seizure-like symptoms (Hübner et al
2001; Tang, 2020; Merner et al., 2015; Kaila et al., 2014). Therefore, KCC2
upregulation, perhaps through treatment with BDNF or other factors, has the potential of
being a safe way to modulate intracellular Cl- levels for therapeutic effects. The fact that
KCC2 is expressed only in neurons makes this approach more promising because specific
upregulation of KCC2 would avoid off-target effects on other physiological systems. For
many cases of autism and epilepsy, there is no known cause and limited treatment
options. Therefore, research on KCC2 should continue to determine whether the extent to
which this protein relates to the etiology of human neurological disorders and whether it
is a good biological target for treatment.
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Appendix

A mixed model ANOVA to examine whether KCC2:mCitrine fluorescence
intensity measured across the pallium and whole brain differed over time. The R code
used to analyze the data are listed below.
A mixed model ANOVA – Pallium KCC2:mCitrine brightness
Pallium2_6dpf$Time<ordered(Pallium2_6dpf$Time, levels=c("2dpf",
"4dpf", "6dpf"))
levels(Pallium2_6dpf$Time)
Pallium2_6dpf$Treatment<-as.factor(Pallium2_6dpf$Treatment)
levels(Pallium2_6dpf$Treatment)
Pallium2_6dpf$Brightness<-as.numeric(Pallium2_6dpf$Brightness)
library(ez)
option(contrasts=c("contr.helmert","contr.poly"))
model2<-ezANOVA(data=Pallium2_6dpf, dv=.("Brightness"),
wid=.(ID), within = .(time), between = .(Treatment), type=3,
detail=TRUE
model2
A mixed model ANOVA – Whole brain KCC2:mCitrine brightness
WholeBrain2_6dpf$Time<ordered(WholeBrain2_6dpf $Time,
levels=c("2dpf", "4dpf", "6dpf"))
levels(WholeBrain2_6dpf$Time)
WholeBrain2_6dpf$Treatment<-as.factor(WholeBrain2_6dpf$Treatment)
levels(WholeBrain2_6dpf$Treatment)
WholeBrain2_6dpf$Brightness<as.numeric(WholeBrain2_6dpf$Brightness)
library(ez)
option(contrasts=c("contr.helmert","contr.poly"))
model1<-ezANOVA(data= WholeBrain2_6dpf, dv=.("Brightness"),
wid=.(ID), within = .(time), between = .(Treatment), type=3,
detail=TRUE
model1
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A one-tailed independent samples t-test was conducted to determine if zebrafish
embryos exposed to 2.5 µM BPA showed the expected increase in spontaneous
locomotor activity compared to controls. The R code used to conduct the one-tailed
independent samples t-test, effect size, standard deviation, and mean are listed below.
t.test(behavioral_KCC2$Locomotor ~ behavioral_KCC2$Treatment,
var.equal = TRUE, alternative = "less")
tapply(behavioral_KCC2$Locomotor, behavioral_KCC2$Treatment,
mean)
tapply(behavioral_KCC2$Locomotor, behavioral_KCC2$Treatment, sd)
lsr::cohensD(behavioral_KCC2$ Locomotor ~
behavioral_KCC2$Treatment)
A one-tailed independent t-test was conducted to determine if there was a
statistically significant brightness intensity increase in CYP19a1b:GFP after BPA
treatment compared to the control. The R code used to conduct the one-tailed
independent samples t-test, effect size, standard deviation, and mean are listed below.
t.test(CYP19_data$Brightness ~ CYP19_data$Treatment, var.equal =
TRUE, alternative = "greater")
tapply(CYP19_data$Brightness, CYP19_data$Treatment, mean)
tapply(CYP19_data$Brightness, CYP19_data$Treatment, sd)
lsr::cohensD(CYP19_data$Brightness ~ CYP19_data$Treatment)

